Kay Ahn
Springhouse(US)Janssen (United States)(US)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Pancreatic function and diabetes, Ubiquitin and proteasome pathways, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Lipid metabolism and biosynthesis
Most-Cited Works
- → SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1(2010)890 cited
- → Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System(2008)518 cited
- → Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain(2009)440 cited
- → Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain(2011)229 cited
- → Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor(2010)196 cited
- → Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders(2009)195 cited
- → Structure-guided inhibitor design for human FAAH by interspecies active site conversion(2008)151 cited
- → PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis(2015)95 cited
- → Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver(2012)90 cited
- → Proteomic discovery of chemical probes that perturb protein complexes in human cells(2023)90 cited